Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine. Fraley E, LeMaster C, Khanal S, Banerjee D, et al. Clin Infect Dis 2021 Sep 22. pii: 6373987. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fraley E, LeMaster C, Khanal S, Banerjee D, et al. Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine. Clin Infect Dis 2021 Sep 22. pii: 6373987. doi: 10.1093.
PMID: 34551091